Mega Lifesciences PCL (BKK:MEGA)
Thailand · Delayed Price · Currency is THB 34.00
-0.25 (-0.73%)
Jun 12, 2026, 4:36 PM ICT
Mega Lifesciences PCL Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Mega Lifesciences PCL stock has a consensus rating of "Buy" and an average price target of ฿41.14. The average 1-year stock price forecast is 21.00% higher than the current stock price, while the lowest is ฿35.00 (+2.94%) and the highest is ฿45.00 (+32.35%).
Price Target: ฿41.14 (+21.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Mega Lifesciences PCL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 0 | 0 | 1 | 1 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 6 | 6 | 7 | 7 |
Financial Forecast
Revenue This Year
14.88B
from 14.19B
Increased by 4.80%
Revenue Next Year
15.61B
from 14.88B
Increased by 4.94%
EPS This Year
2.66
from 2.34
Increased by 13.75%
EPS Next Year
2.85
from 2.66
Increased by 7.20%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.4B | ||
| Avg | 14.9B | ||
| Low | 13.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.4% | ||
| Avg | 4.8% | ||
| Low | -1.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.88 | ||
| Avg | 2.66 | ||
| Low | 2.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 23.1% | ||
| Avg | 13.7% | ||
| Low | 8.1% |